News

Toray Industries, Inc., and Jolly Good Inc. announced that they have jointly developed HotBalloon™ Ablation: A VR Tour. This virtual reality (VR) content is a platform for ablation training with Satake HotBalloon®,1 Toray’s catheter ablation...

Southcoast Health is enrolling patients in a new clinical trial to evaluate the use of a new heart ablation technology designed to treat atrial fibrillation, officials announced.   The community health system’s Cardiovascular Care Center at...

CorSystem announces the first use of their Bipolar Ablation Adapter since the device received CE mark in July 2020. The patient who underwent treatment was suffering from a VT storm, a life-threatening cardiac condition that required frequent...

Research team includes Geisinger, Tempus scientists A team of scientists from Geisinger and Tempus have found that artificial intelligence can predict risk of new atrial fibrillation (AF) and AF-related stroke. Atrial fibrillation is the...

ControlRad has entered into an exclusive agreement with Boston Scientific Corporation to sell the ControlRad Select technology.  ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary...

Study will determine the safety and effectiveness of pulsed electrical fields to interrupt irregular heart rhythms Medtronic plc, the global leader in medical technology, announced the first procedures in the investigational device exemption...

The Heart Failure Society of America (HFSA), the Heart Failure Association of the European Society of Cardiology (HFA-ESC) and the Japanese Heart Failure Society (JHFS) announced a new Universal Definition and Classification of Heart Failure,...

Contract pricing now widely available for the AcQMap® High Resolution 3D Imaging and Mapping System Acutus Medical announced that it has received an Innovative Technology contract from Vizient, Inc., the largest, member-driven healthcare...

Findings highlight need to better classify heart failure outcomes Medtronic plc, the global leader in medical technology, announced new results from the landmark REVERSE trial, evaluating outcomes of cardiac resynchronization therapy (CRT)...

Imricor Medical Systems, Inc. the global leader in MRI-guided cardiac ablation products, is pleased to announce the Maastricht University Medical Centre+ (MUMC+) in the Netherlands has commenced procedures since the extended lockdowns across...